Chemotactic Peptide-induced Changes of Intermediate Filament Organization in Neutrophils during Granule Secretion: Role of Cyclic Guanosine Monophosphate

Tekijä Pryzwansky, Katherine B., Merricks, Elizabeth P.
Julkaistu 1998

ARFI Imaging for Noninvasive Material Characterization of Atherosclerosis Part II: Toward In Vivo Characterization

Tekijä Behler, Russell H., Nichols, Timothy C., Zhu, Hongtu, Merricks, Elizabeth P., Gallippi, Caterina M.
Julkaistu 2008

Global measurement of coagulation in plasma from normal and haemophilia dogs using a novel modified thrombin generation test – Demonstrated in vitro and ex vivo

Tekijä Madsen, Daniel Elenius, Nichols, Timothy C., Merricks, Elizabeth P., Waters, Emily K., Wiinberg, Bo
Julkaisussa PLoS One (2017)

Preclinical evaluation of a next-generation, subcutaneously administered, coagulation factor IX variant, dalcinonacog alfa

Tekijä Nichols, Timothy C., Levy, Howard, Merricks, Elizabeth P., Raymer, Robin A., Lee, Martin L.
Julkaisussa PLoS One (2020)

Influence of Diabetes on the Foreign Body Response to Nitric Oxide-Releasing Implants

Tekijä Soto, Robert J., Merricks, Elizabeth P., Bellinger, Dwight A., Nichols, Timothy C., Schoenfisch, Mark H.
Julkaisussa Biomaterials (2017)

Phase II Prospective Open-Label Trial of Recombinant Interleukin-11 in DDAVP-Unresponsive Von Willebrand Disease and Mild or Moderate Hemophilia A

Tekijä Ragni, Margaret V., Novelli, Enrico M., Murshed, Anila, Merricks, Elizabeth P., Kloos, Mark T., Nichols, Timothy C.
Julkaistu 2012

Phase II prospective open-label trial of recombinant interleukin-11 in women with mild von Willebrand disease and refractory menorrhagia()

Tekijä Ragni, Margaret V., Jankowitz, Rachel C., Jaworski, Kristen, Merricks, Elizabeth P., Kloos, Mark T., Nichols, Timothy C.
Julkaistu 2011

Animal Models of Hemophilia

Tekijä Sabatino, Denise E., Nichols, Timothy C., Merricks, Elizabeth, Bellinger, Dwight A., Herzog, Roland W., Monahan, Paul E.
Julkaistu 2012

Soy phosphatidylinositol containing lipid nanoparticle prolongs the plasma survival and hemostatic efficacy of B-domain deleted recombinant canine Factor VIII in Hemophilia A dogs

Tekijä Shetty, Krithika A., Merricks, Elizabeth P., Raymer, Robin, Rigsbee, Natalie, Nichols, Timothy C, Balu-Iyer, Sathy V.
Julkaisussa J Pharm Sci (2016)

Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells

Tekijä Haberichter, Sandra L., Merricks, Elizabeth P., Fahs, Scot A., Christopherson, Pamela A., Nichols, Timothy C., Montgomery, Robert R.
Julkaistu 2004

Portal Vein Delivery of Viral Vectors for Gene Therapy for Hemophilia

Tekijä Sherman, Alexandra, Schlachterman, Alexander, Cooper, Mario, Merricks, Elizabeth P., Raymer, Robin A., Bellinger, Dwight A., Herzog, Roland W., Nichols, Timothy C.
Julkaisussa Methods Mol Biol (2014)

Experimental Validation of ARFI Surveillance of Subcutaneous Hemorrhage (ASSH) Using Calibrated Infusions in a Tissue-Mimicking Model and Dogs

Tekijä Geist, Rebecca E., DuBois, Chase H., Nichols, Timothy C., Caughey, Melissa C., Merricks, Elizabeth P., Raymer, Robin, Gallippi, Caterina M.
Julkaisussa Ultrason Imaging (2015)

A Monoclonal Antibody Against α(V)β(3) Integrin Inhibits Development of Atherosclerotic Lesions in Diabetic Pigs

Tekijä Maile, Laura A., Busby, Walker H., Nichols, Timothy C., Bellinger, Dwight A., Merricks, Elizabeth P., Rowland, Michael, Veluvolu, Umadevi, Clemmons, David R.
Julkaistu 2010

Severe Hemophilia A in a Male Old English Sheep Dog with a C→T Transition that Created a Premature Stop Codon in Factor VIII

Tekijä Lozier, Jay N, Kloos, Mark T, Merricks, Elizabeth P, Lemoine, Nathaly, Whitford, Margaret H, Raymer, Robin A, Bellinger, Dwight A, Nichols, Timothy C
Julkaisussa Comp Med (2016)

Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models

Tekijä Markusic, David M., Nichols, Timothy C., Merricks, Elizabeth P., Palaschak, Brett, Zolotukhin, Irene, Marsic, Damien, Zolotukhin, Sergei, Srivastava, Arun, Herzog, Roland W.
Julkaisussa J Transl Med (2017)

Complete correction of hemophilia B phenotype by FIX-Padua skeletal muscle gene therapy in an inhibitor-prone dog model

Tekijä French, Robert A., Samelson-Jones, Benjamin J., Niemeyer, Glenn P., Lothrop, Clinton D., Merricks, Elizabeth P., Nichols, Timothy C., Arruda, Valder R.
Julkaisussa Blood Adv (2018)

Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants

Tekijä Samelson-Jones, Benjamin J., Finn, Jonathan D., Raffini, Leslie J., Merricks, Elizabeth P., Camire, Rodney M., Nichols, Timothy C., Arruda, Valder R.
Julkaisussa Blood Adv (2021)

Hyperactive Sleeping Beauty Transposase Enables Persistent Phenotypic Correction in Mice and a Canine Model for Hemophilia B

Tekijä Hausl, Martin A, Zhang, Wenli, Müther, Nadine, Rauschhuber, Christina, Franck, Helen G, Merricks, Elizabeth P, Nichols, Timothy C, Kay, Mark A, Ehrhardt, Anja
Julkaistu 2010

Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies

Tekijä Nichols, Timothy C., Bellinger, Dwight A., Merricks, Elizabeth P., Raymer, Robin A., Kloos, Mark T., DeFriess, Natalie, Ragni, Margaret V., Griggs, Thomas R.
Julkaistu 2010

The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapy

Tekijä Finn, Jonathan D., Nichols, Timothy C., Svoronos, Nikolaos, Merricks, Elizabeth P., Bellenger, Dwight A., Zhou, Shangshen, Simioni, Paolo, High, Katherine A., Arruda, Valder R.
Julkaistu 2012